About Us
Dalos BioPharma was founded in Virginia Beach in 2008. At Dalos it is our goal to provide effective skin care using our multi-faceted plant-derived flavokines™, while maintaining the scientific integrity of the product. Unlike companies that sell “natural” products based on loose generalizations of potential activity, Dalos’ products are all evidence-based.
The President & CEO of Dalos, Dr. Gary Pekoe, has been participating in the development of successful, effective topical antiviral and antibacterial agents for over 20 years. Dr. Pekoe has observed that in his years of experience, it has been rare to have seen a product, especially a botanical, that has shown this sort of effectiveness and safety as a topical. He is very excited to be involved with this product that treats such important and troublesome skin problems as MRSA and Molluscum.
Our Team
GARY PEKOE, Ph.D.
President/CEO
Dr. Pekoe has over 25 years experience in successful dermatological (and other) product development. He directed the successful clinical development of Bactroban®, the first FDA-approved single agent topical prescription antibiotic. Dr. Pekoe has been a successful entrepreneur for the past 15 years through his consulting practice, Arkios BioDevelopment.

|
JOHN THOMPSON
Director of Sales
John Thompson, Director of Sales, is a senior pharmaceutical sales executive (ret). He has recent experience with 3M, launching new products into the dermatology market. Mr. Thompson is familiar with the markets that are targets for Dalos’ products and has extensive relationships with thought leaders across the country in dermatology.

|
KIRBY QUERY, MS
Product Development Specialist
Kirby is responsible for consulting on and implementing the clinical development, formulation/manufacturing, product/packaging design, and marketing and sales goals of the Dalos team. She has specific experience in dermatologic clinical development with Arkios BioDevelopment has prior experience with product branding and sales. Kirby received her MS in Pharmaceutical Science from University of Florida. |
AMANDA HOUCK MILLER, MS
Regulatory Affairs Consultant
Amanda oversees the quality management of our clinical projects and provides regulatory guidance on all phases of production from label design to product manufacturing. She has worked with the CRO, Arkios BioDevelopment, as the Regulatory Affairs Manager for over two years. Amanda received MS in Biology from the College of William and Mary. |
LINDSEY NATHANIEL
Vice President, Operations
Lindsey manages all business related aspects of Dalos including investor relations, accounting, sales and marketing strategy, product development, and daily company operations. Lindsey has held a range of management positions and has extensive and valuable sales experience. |
BRIANNA WILLIAMS
Administrative Assistant
Brianna is responsible for the daily business and customer service-related aspects of Dalos. She is the first line of communication with the customer and ensures that all product shipments and customer inquiries are processed correctly and efficiently. She has broad experience in the customer service industry. |
Scientific Advisory Board
JUDITH WILLIMS, MD
Eastern Virginia Medical School, Department of Dermatology
Dr. Williams is board certified in Pediatric Dermatology with clinical interests and skills in vascular malformations. She received her medical degree from Pennsylvania State University of Medicine, completed her internship at Ohio State University School of Medicine, Columbus Children’s Hospital and her residencies at Ohio State, Columbus Children’s Hospital (Pediatrics) and Penn State (Dermatology).
Dr. Williams completed her fellowship training in Pediatric Dermatology at Children’s Hospital and Health Center, San Diego, CA. She is a member of the American Academy of Dermatology, the American Academy of Pediatrics, and the Society for Pediatric Dermatology. Her current Practice is located at Children’s Hospital of The King’s Daughters, 601 Children’s Lane, Norfolk, VA 23507. |
DENNIS WEST, PhD
Northwestern University, Department of Dermatology
Dr. Dennis West is the Vincent W. Foglia Family Research Professor of Dermatology and the Director of the Dermatopharmacology/ Clinical Research Program at Northwestern University's Feinberg School of Medicine. He is also a Professor for the College of Pharmacy at the University of Illinois at Chicago, a Chair for Administrative Review for the Institutional Review Board for the Office for the Protection of Research Subjects at Northwestern University and a Lecturer for the MD/PhD Program in the Department of Dermatology at the University of Catania, Italy. He received his M.S. from the University of Iowa College of Pharmacy and his Ph.D. in Pharmacology from Pacific Western University in Louisiana. Dr. West is an internationally known expert in dermatopharmacology, particularly in the area of percutaneous absorption and systemic and topical therapy for skin disorders. He is the new Dermatology Chair for the USP DI (United States Pharmacopeia Drug Information). |
ARNOLD OPPENHEIM, MD
Virginia Beach Dermatology
Dr. Oppenheim attended Antioch College for his undergraduate studies and received his medical degree from Boston University School of Medicine. He completed an internship at Johns Hopkins and following residencies in pathology at Massachusetts General Hospital and Dartmouth-Hitchcock Medical Center, Dr. Oppenheim decided he most of all wanted to become a dermatologist. He underwent his dermatology training at Mt. Sinai Medical Center of Miami Beach under the tutelage of renowned dermatopharmacologist, Dr. Philip Frost. He then completed his pathology residency at Yale-New Haven Hospital. Aside from his thriving dermatology practice in Virginia Beach for the past 27 years, Dr. Oppenheim also served as a major for 8 years with the 18th Field Hospital of the United States Army Reserve, as a family physician in South Boston, Virginia and as a general physician with the Indian Health Service in Poplar, Montana. He serves as an Assistant Professor of Dermatology at Eastern Virginia Medical School and is on the active staff at Sentara Virginia Beach General and Sentara Bayside Hospitals. |
KNOX VAN DYKE, PhD
West Virginia University, Department of Biochemistry
Dr. Van Dyke completed his undergraduate studies at Knox College and received his PhD from Saint Louis University. His postdoctoral training was completed at West Virginia University, where he is currently serving as a Professor in the Department of Biochemistry and as a part of the WVU Interdepartmental Graduate Program in Genetics. Dr. Van Dyke conducts research centered in chemotherapy and inflammation where he and his team are developing new methods (including genetic probes) to control diseases such as black lung, silicosis, fibrosis and emphysema. |
JAMES LEYDEN, MD
University of Pennsylvania, Department of Dermatology
Dr. Leyden serves as an Emeritus Professor of Dermatology for the University of Pennsylvania and as a consultant for major pharmaceutical companies. He received his medical degree from University of Pennsylvania School of Medicine, completed his internship at Temple University Hospital and his residency at the Hospital of the University of Pennsylvania. |
|
|